• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.中澳两国的故事:博茨瓦纳和澳大利亚在实现 UNAIDS 90-90-90 目标方面的进展。
J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25090.
2
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?普及检测与治疗试验向我们揭示了实现艾滋病流行控制的道路?
J Int AIDS Soc. 2020 Feb;23(2):e25455. doi: 10.1002/jia2.25455.
3
Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.博茨瓦纳基于社区的干预措施后艾滋病毒检测、治疗、病毒抑制和男性割礼的人群参与情况(Ya Tsie/BCPP):一项集群随机试验。
Lancet HIV. 2020 Jun;7(6):e422-e433. doi: 10.1016/S2352-3018(20)30103-X.
4
Progress towards the UNAIDS 95-95-95 targets in the Fifth Botswana AIDS Impact Survey (BAIS V 2021): a nationally representative survey.迈向联合国艾滋病规划署 95-95-95 目标的进展:博茨瓦纳第五次艾滋病影响调查(BAIS V 2021):一项全国代表性调查。
Lancet HIV. 2024 Apr;11(4):e245-e254. doi: 10.1016/S2352-3018(24)00003-1. Epub 2024 Mar 8.
5
Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.博茨瓦纳在实现 2020 年艾滋病署 90-90-90 抗逆转录病毒治疗和病毒学抑制目标方面的进展:一项基于人群的调查。
Lancet HIV. 2016 May;3(5):e221-30. doi: 10.1016/S2352-3018(16)00037-0. Epub 2016 Mar 24.
6
Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.南非夸祖鲁-纳塔尔省农村地区感染艾滋病毒的孕妇和妇女中的病毒抑制情况:评估实现艾滋病规划署指标的进展情况以及对艾滋病毒流行控制的影响的横断面研究。
Reprod Health. 2022 May 12;19(1):116. doi: 10.1186/s12978-022-01419-5.
7
Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.在博茨瓦纳实施普遍艾滋病毒检测和治疗以降低艾滋病毒发病率:Ya Tsie 研究。
Curr HIV/AIDS Rep. 2020 Oct;17(5):478-486. doi: 10.1007/s11904-020-00523-0.
8
Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.迈向实现 90-90-90 艾滋病毒目标:南非 2017 年全国艾滋病毒调查结果。
BMC Public Health. 2020 Sep 9;20(1):1375. doi: 10.1186/s12889-020-09457-z.
9
Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa.实现艾滋病规划署 90-90-90 目标:在撒哈拉以南非洲地区开展普遍检测和治疗以减少艾滋病毒传播的四项大型社区随机试验的比较分析。
BMC Public Health. 2022 Dec 13;22(1):2333. doi: 10.1186/s12889-022-14713-5.
10
Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response.超越“90-90-90”目标:重新聚焦将艾滋病病毒预防作为全球艾滋病应对工作的一部分。
J Int AIDS Soc. 2016 Dec 19;19(1):21348. doi: 10.7448/IAS.19.1.21348. eCollection 2016.

引用本文的文献

1
Prospective longitudinal assessment of Albumin-to-Creatinine ratio (ACR) in a clinical cohort of people living with HIV in Gaborone, Botswana.对博茨瓦纳哈博罗内市一个艾滋病毒感染者临床队列中的白蛋白与肌酐比值(ACR)进行前瞻性纵向评估。
BMC Infect Dis. 2025 Mar 7;25(1):327. doi: 10.1186/s12879-025-10721-z.
2
High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana.博茨瓦纳非公民艾滋病毒感染者中治疗前和获得性艾滋病毒-1耐药突变的高流行率。
Front Microbiol. 2024 Feb 20;15:1338191. doi: 10.3389/fmicb.2024.1338191. eCollection 2024.
3
Process evaluation of the 90-90-90 targets of surge project in Addis Ababa, Ethiopia: a case study evaluation.埃塞俄比亚亚的斯亚贝巴“90-90-90 目标推进项目”的过程评估:案例研究评估。
BMC Health Serv Res. 2024 Jan 2;24(1):5. doi: 10.1186/s12913-023-10415-9.
4
HIV-Related Knowledge and Practices among Asian and African Migrants Living in Australia: Results from a Cross-Sectional Survey and Qualitative Study.在澳亚洲和非洲移民的艾滋病相关知识与行为:横断面调查与定性研究结果。
Int J Environ Res Public Health. 2023 Feb 28;20(5):4347. doi: 10.3390/ijerph20054347.
5
Causal Structural Learning on MPHIA Individual Dataset.MPHIA个体数据集上的因果结构学习
J Am Stat Assoc. 2022;117(540):1642-1655. doi: 10.1080/01621459.2022.2077209. Epub 2022 Jul 7.
6
Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya.肯尼亚常规 HIV 规划中普遍检测和治疗对 12 个月的保留率和初始病毒学抑制的影响。
PLoS One. 2022 Nov 22;17(11):e0277675. doi: 10.1371/journal.pone.0277675. eCollection 2022.
7
Progress towards 2020 global HIV impact and treatment targets.迈向 2020 年全球艾滋病毒影响和治疗目标的进展。
J Int AIDS Soc. 2021 Sep;24 Suppl 5(Suppl 5):e25779. doi: 10.1002/jia2.25779.
8
Overview of systematic reviews on strategies to improve treatment initiation, adherence to antiretroviral therapy and retention in care for people living with HIV: part 1.关于改善艾滋病毒感染者治疗启动、抗逆转录病毒治疗依从性及护理留存率策略的系统评价概述:第1部分
BMJ Open. 2020 Sep 23;10(9):e034793. doi: 10.1136/bmjopen-2019-034793.
9
Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials.整合和解读最新治疗即预防试验的结果。
Curr HIV/AIDS Rep. 2020 Jun;17(3):249-258. doi: 10.1007/s11904-020-00492-4.
10
The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead.拉丁美洲的艾滋病疫情:是时候反思成功历程与未来挑战了。
J Int AIDS Soc. 2020 Mar;23(3):e25468. doi: 10.1002/jia2.25468.

本文引用的文献

1
Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in Australia.实现 90-90-90 人类免疫缺陷病毒 (HIV) 目标将不足以实现澳大利亚的 HIV 发病率降低目标。
Clin Infect Dis. 2018 Mar 19;66(7):1019-1023. doi: 10.1093/cid/cix939.
2
Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.社会经济因素解释了澳大利亚病毒得到抑制的HIV感染成年患者对抗逆转录病毒疗法依从性欠佳的原因。
PLoS One. 2017 Apr 3;12(4):e0174613. doi: 10.1371/journal.pone.0174613. eCollection 2017.
3
Achieving development goals for HIV, tuberculosis and malaria in sub-Saharan Africa through integrated antenatal care: barriers and challenges.通过综合产前保健在撒哈拉以南非洲实现艾滋病、结核病和疟疾的发展目标:障碍与挑战
BMC Med. 2016 Dec 12;14(1):202. doi: 10.1186/s12916-016-0753-9.
4
Community-Based ART Programs: Sustaining Adherence and Follow-up.基于社区的抗逆转录病毒治疗项目:维持依从性与随访
Curr HIV/AIDS Rep. 2016 Dec;13(6):359-366. doi: 10.1007/s11904-016-0335-7.
5
Financing the HIV response in sub-Saharan Africa from domestic sources: Moving beyond a normative approach.撒哈拉以南非洲地区利用国内资源应对艾滋病:超越规范性方法。
Soc Sci Med. 2016 Nov;169:66-76. doi: 10.1016/j.socscimed.2016.09.027. Epub 2016 Sep 19.
6
Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.瑞典是首个实现联合国艾滋病规划署(UNAIDS)/世界卫生组织(WHO)提出的艾滋病治疗90-90-90连续目标的国家。
HIV Med. 2017 Apr;18(4):305-307. doi: 10.1111/hiv.12431. Epub 2016 Aug 18.
7
What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.到2030年将艾滋病疫情作为公共卫生威胁终结需要什么?快速通道方法的成本与影响。
PLoS One. 2016 May 9;11(5):e0154893. doi: 10.1371/journal.pone.0154893. eCollection 2016.
8
Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.博茨瓦纳在实现 2020 年艾滋病署 90-90-90 抗逆转录病毒治疗和病毒学抑制目标方面的进展:一项基于人群的调查。
Lancet HIV. 2016 May;3(5):e221-30. doi: 10.1016/S2352-3018(16)00037-0. Epub 2016 Mar 24.
9
Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.在资源匮乏地区扩大常规病毒载量检测:当前及未来的实施挑战
Clin Infect Dis. 2016 Apr 15;62(8):1043-8. doi: 10.1093/cid/ciw001. Epub 2016 Jan 6.
10
The HIV care cascade: a systematic review of data sources, methodology and comparability.艾滋病病毒治疗级联:对数据来源、方法及可比性的系统评价
J Int AIDS Soc. 2015 Nov 30;18(1):20634. doi: 10.7448/IAS.18.1.20634. eCollection 2015.

中澳两国的故事:博茨瓦纳和澳大利亚在实现 UNAIDS 90-90-90 目标方面的进展。

A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.

机构信息

Public Health, Burnet Institute, Melbourne, Vic., Australia.

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia.

出版信息

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25090.

DOI:10.1002/jia2.25090
PMID:29508945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5838412/
Abstract

UNAIDS 90-90-90 targets and Fast-Track commitments are presented as precursors to ending the AIDS epidemic by 2030, through effecting a 90% reduction in new HIV infections and AIDS-related deaths from 2010 levels (HIV epidemic control). Botswana, a low to middle-income country with the third-highest HIV prevalence, and Australia, a low-prevalence high-income country with an epidemic concentrated among men who have sex with men (MSM), have made significant strides towards achieving the UNAIDS 90-90-90 targets. These two countries provide lessons for different epidemic settings. This paper discusses the lessons that can be drawn from Botswana and Australia with respect to their success in HIV testing, treatment, viral suppression and other HIV prevention strategies for HIV epidemic control. Botswana and Australia are on target to achieving the 90-90-90 targets for HIV epidemic control, made possible by comprehensive HIV testing and treatment programmes in the two countries. As of 2015, 70% of all people assumed to be living with HIV had viral suppression in Botswana and Australia. However, HIV incidence remains above one per cent in the general population in Botswana and in MSM in Australia. The two countries have demonstrated that rapid HIV testing that is accessible and targeted at key and vulnerable populations is required in order to continue identifying new HIV infections. All citizens living with HIV in both countries are eligible for antiretroviral therapy (ART) and viral load monitoring through government-funded programmes. Notwithstanding their success in reducing HIV transmission to date, programmes in both countries must continue to be supported at current levels to maintain epidemic suppression. Scaled HIV testing, linkage to care, universal ART, monitoring patients on treatment over and above strengthened HIV prevention strategies (e.g. male circumcision and pre-exposure prophylaxis) will all continue to require funding. The progress that Botswana and Australia have made towards meeting the 90-90-90 targets is commendable. However, in order to reduce HIV incidence significantly towards 2030, there is a need for sustained HIV testing, linkage to care and high treatment coverage. Botswana and Australia provide useful lessons for developing countries with generalized epidemics and high-income countries with concentrated epidemics.

摘要

UNAIDS 90-90-90 目标和快速通道承诺被视为 2030 年终结艾滋病流行的前提,目标是实现 2010 年以来新感染艾滋病毒人数和艾滋病相关死亡人数减少 90%(艾滋病毒疫情控制)。博茨瓦纳是一个中低收入国家,艾滋病毒流行率居世界第三,澳大利亚是一个艾滋病毒流行率较低的高收入国家,疫情主要集中在男男性行为者(MSM)中,这两个国家在实现 UNAIDS 90-90-90 目标方面取得了重大进展。这两个国家为不同的疫情环境提供了经验教训。本文讨论了博茨瓦纳和澳大利亚在艾滋病毒检测、治疗、病毒抑制和其他艾滋病毒防控策略方面取得成功的经验教训。博茨瓦纳和澳大利亚正在实现艾滋病毒疫情控制的 90-90-90 目标,这得益于两国全面的艾滋病毒检测和治疗方案。截至 2015 年,博茨瓦纳和澳大利亚所有被认为携带艾滋病毒的人中,有 70%的人实现了病毒抑制。然而,博茨瓦纳普通人群和澳大利亚男男性行为者中的艾滋病毒发病率仍高于 1%。这两个国家表明,需要快速进行艾滋病毒检测,检测应具有可及性并针对重点和脆弱人群,以便继续发现新的艾滋病毒感染。两国所有携带艾滋病毒的公民都有资格通过政府资助的方案获得抗逆转录病毒疗法(ART)和病毒载量监测。尽管这两个国家迄今在减少艾滋病毒传播方面取得了成功,但为了维持疫情抑制,仍必须继续维持目前的水平支持这些方案。扩大艾滋病毒检测、将感染者转至治疗服务、普及抗逆转录病毒治疗、对强化艾滋病毒防控策略(如男性割礼和暴露前预防)进行监测,所有这些都将继续需要资金。博茨瓦纳和澳大利亚在实现 90-90-90 目标方面取得的进展值得称赞。然而,为了在 2030 年前大幅降低艾滋病毒发病率,需要持续进行艾滋病毒检测、将感染者转至治疗服务并提高治疗覆盖率。博茨瓦纳和澳大利亚为广泛流行的发展中国家和集中流行的高收入国家提供了有用的经验教训。